Clinical Trial Update: Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare [Phase 2, Phase 3]

View source ↗

Summary

Olatec Therapeutics is conducting a Phase 2/3 study of Dapansutrile tablets in subjects with an acute gout flare; the trial status is recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arthritis
• Gout

Drugs mentioned

• Dapansutrile (dapansutrile)

Snippet

Sponsor: Olatec Therapeutics LLC | Conditions: Acute Gout Flare, Gout Attack | Phase 2, Phase 3 | Status: RECRUITING